For any enquiry about our products, please phone us on +34 917 991 564 |info@finabiotech.es

Timeline

Timeline2019-01-18T15:46:35+01:00

junio 2021

agosto 2019

marzo 2019

Press-release: FINA BIOTECH has successfully validated the results of its bladder cancer diagnostic test in Chinese population

Fina Biotech has successfully validated the previously reported European study results of its bladder cancer diagnostic test in an independent Asian cohort. The prospective blinded study was carried out at the Fudan University Shanghai Cancer [...]

octubre 2018

Press-release: FINA BIOTECH announces its merger by absorption with BIOFINA DIAGNOSTICS

FINA BIOTECH (acquiring company) has recently completed its merger by absorption with BIOFINA DIAGNOSTICS (acquired company). Both companies took the decision in their respective shareholders´ meeting last June. The combination amplifies FINA BIOTECH´s expertise and [...]

mayo 2018

Press release – Fina Biotech reinforces its IP portfolio with a new patent in the USA

Fina Biotech announces that the United States Patent and Trademark Office (USPTO) has recently granted patent number 9,902,998 to protect a ´NON-INVASIVE DIAGNOSTIC METHOD FOR DIAGNOSING BLADDER CANCER´. The patent will be in force until [...]

abril 2017

Press release – Biofina Diagnostics is awarded with a Seal of Excellence by the European Commission

Biofina Diagnostics S.L has been recently awarded with a Seal of Excellence by the European Commission following the presentation of its project proposal UROBEST ´UROthelial carcinoma Biomarker based diagnostic tEST´ Submitted under the Horizon 2020’s [...]

Go to Top